4/A: Aadi Bioscience CFO Receives Stock Grant
Insider Transaction (Form 4/A)
Scott M. Giacobello, CHIEF FINANCIAL OFFICER of Aadi Bioscience, Inc., reported multiple transactions in common stock on September 15, 2026.
Summary
- Grant/award: acquired 118,476 Stock Option (right to buy) on September 15, 2026; holds 118,476 after (Direct).
- Grant/award: acquired 118,476 Restricted Stock Units on September 15, 2026; holds 118,476 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Scott M. Giacobello — Officer (CHIEF FINANCIAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Grant/award | Stock Option (right to buy) | 118,476 | — | — | 118,476 |
| 2026-09-15 | Grant/award | Restricted Stock Units | 118,476 | — | — | 118,476 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Grant/award (118,476 shares) |
| 2026-09-15 | Grant/award (118,476 shares) |
Keywords
insider transaction, Form 4/A, WHWK, Whitehawk Therapeutics, Inc., neutral, Scott M. Giacobello
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.